Search Results - "Schlör, Anja"

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications by Schlör, Anja, Hirschberg, Stefan, Amor, Ghada Ben, Meister, Toni Luise, Arora, Prerna, Pöhlmann, Stefan, Hoffmann, Markus, Pfaender, Stephanie, Eddin, Omar Kamal, Kamhieh-Milz, Julian, Hanack, Katja

“…IntroductionThe ongoing COVID-19 pandemic situation caused by SARS-CoV-2 and variants of concern such as B.1.617.2 (Delta) and recently, B.1.1.529 (Omicron) is…”
Get full text

A New Workflow to Generate Monoclonal Antibodies against Microorganisms by Göthel, Markus, Listek, Martin, Messerschmidt, Katrin, Schlör, Anja, Hönow, Anja, Hanack, Katja

“…Monoclonal antibodies are used worldwide as highly potent and efficient detection reagents for research and diagnostic applications. Nevertheless, the specific…”
Get full text

An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line by Hirschberg, Stefan, Ghazaani, Fatemeh, Ben Amor, Ghada, Pydde, Markus, Nagel, Alexander, Germani, Saveria, Monica, Lara, Schlör, Anja, Bauer, Hannes, Hornung, Jane, Voetz, Michael, Dwai, Yamen, Scheer, Benjamin, Ringel, Frauke, Kamal-Eddin, Omar, Harms, Christoph, Füner, Jonas, Adrian, Lorenz, Pruß, Axel, Schulze-Forster, Kai, Hanack, Katja, Kamhieh-Milz, Julian

“…The rapid evolution of new SARS-CoV-2 variants poses a continuing threat to human health. Vaccination has become the primary therapeutic intervention. The goal…”
Get full text

Neuroprotection by Caffeine in Hyperoxia-Induced Neonatal Brain Injury by Endesfelder, Stefanie, Weichelt, Ulrike, Strauß, Evelyn, Schlör, Anja, Sifringer, Marco, Scheuer, Till, Bührer, Christoph, Schmitz, Thomas

“…Sequelae of prematurity triggered by oxidative stress and free radical-mediated tissue damage have coined the term "oxygen radical disease of prematurity"…”
Get full text

Analysis of antibodies from whole-cell immunization by a tANCHOR cell-based ELISA by Bernauer, Hubert, Schlör, Anja, Maier, Josef, Hanack, Katja, Bannert, Norbert, Ivanusic, Daniel

“…Monitoring specific antibodies derived from whole-cell immunization through cell-based ELISA methods poses challenges due to humoral responses against various…”
Get full text

tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2 by Bernauer, Hubert, Schlör, Anja, Maier, Josef, Bannert, Norbert, Hanack, Katja, Ivanusic, Daniel

“…Abstract Successful induction of antibodies in model organisms like mice depends strongly on antigen design and delivery. New antigen designs for immunization…”
Get full text

Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2 by Schlör, Anja, Holzlöhner, Pamela, Listek, Martin, Grieß, Cindy, Butze, Monique, Micheel, Burkhard, Hentschel, Christian, Sowa, Mandy, Roggenbuck, Dirk, Schierack, Peter, Füner, Jonas, Schliebs, Erik, Goihl, Alexander, Reinhold, Dirk, Hanack, Katja

“…•Two murine monoclonal antibodies and four recombinant camelid antibodies specific for GP2 were developed and characterised.•One murine monoclonal antibody is…”
Get full text

Camelid nanobodies specific to human pancreatic glycoprotein 2 by Hanack, Katja, Schlör, Anja, Holzlöhner, Pamela, Listek, Martin, Bauer, Cindy, Butze, Monique, Micheel, Burkhard, Hentschel, Christian, Sowa, Mandy, Roggenbuck, Dirk, Schierack, Peter, Füner, Jonas, Schliebs, Erik, Goihl, Alexander, Reinhold, Dirk

“…Pancreatic secretory zymogen-granule membrane glycoprotein 2 (GP2) has been identified to be a major autoantigenic target in Crohn’s disease patients. It was…”
Get full text